Lifeist Wellness Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Lifeist Wellness te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Retail Distributors winstgroei	9.2%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Recent updates

Little Excitement Around Lifeist Wellness Inc.'s (CVE:LFST) Revenues As Shares Take 33% Pounding

Oct 28

Risks To Shareholder Returns Are Elevated At These Prices For Lifeist Wellness Inc. (CVE:LFST)

Sep 06

Lacklustre Performance Is Driving Lifeist Wellness Inc.'s (CVE:LFST) 50% Price Drop

May 04

Lacklustre Performance Is Driving Lifeist Wellness Inc.'s (CVE:LFST) 50% Price Drop

Mar 19

Lacklustre Performance Is Driving Lifeist Wellness Inc.'s (CVE:LFST) 33% Price Drop

Feb 03

Lifeist Wellness Inc. (CVE:LFST) Stock Rockets 50% As Investors Are Less Pessimistic Than Expected

Dec 20

Sentiment Still Eluding Lifeist Wellness Inc. (CVE:LFST)

Apr 17

If You Had Bought Namaste Technologies' (CVE:N) Shares Three Years Ago You Would Be Down 89%

Jan 14

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Lifeist Wellness onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

TSXV:LFST - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CAD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
8/31/2024	15	-14	0	0	N/A
5/31/2024	18	-14	0	0	N/A
2/29/2024	21	-13	0	0	N/A
11/30/2023	22	-14	-3	-2	N/A
8/31/2023	23	-11	-3	-3	N/A
5/31/2023	25	-12	-6	-5	N/A
2/28/2023	25	-16	-15	-14	N/A
11/30/2022	22	-19	-16	-15	N/A
8/31/2022	22	-14	-21	-21	N/A
5/31/2022	20	-18	-23	-23	N/A
2/28/2022	20	-19	-20	-19	N/A
11/30/2021	21	-22	-19	-18	N/A
8/31/2021	23	-25	-18	-17	N/A
5/31/2021	23	-27	-19	-17	N/A
2/28/2021	25	-26	-20	-17	N/A
11/30/2020	25	-26	-28	-25	N/A
8/31/2020	22	-50	-35	-31	N/A
5/31/2020	20	-56	-35	-32	N/A
2/29/2020	17	-60	-39	-37	N/A
11/30/2019	16	-63	-40	-38	N/A
8/31/2019	18	-47	N/A	N/A	N/A
5/31/2019	18	-41	N/A	N/A	N/A
2/28/2019	18	-40	N/A	N/A	N/A
11/30/2018	19	-33	-17	-14	N/A
8/31/2018	19	-23	-14	-12	N/A
5/31/2018	19	-26	N/A	-9	N/A
2/28/2018	18	-21	N/A	-7	N/A
11/30/2017	14	-19	N/A	-7	N/A
8/31/2017	11	-17	N/A	-8	N/A
5/31/2017	8	-7	N/A	-6	N/A
2/28/2017	6	-4	N/A	-4	N/A
11/30/2016	4	-3	N/A	-3	N/A
8/31/2016	3	-2	N/A	-2	N/A
5/31/2016	4	0	N/A	-1	N/A
2/29/2016	4	0	N/A	0	N/A
11/30/2015	5	0	N/A	1	N/A
8/31/2015	5	0	N/A	0	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van LFST boven de spaarquote ( 2.3% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van LFST naar verwachting sneller zal groeien dan de markt Canadian

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van LFST naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van LFST naar verwachting sneller zal groeien dan de markt Canadian.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van LFST naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van LFST naar verwachting over 3 jaar hoog zal zijn

Lifeist Wellness Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Lifeist Wellness Inc. Provides Earnings Guidance for the Third Quarter of Fiscal Year 2021

Price target lowered to CA$0.55

Analysts update estimates

Recent updates

Lifeist Wellness Inc. Appoints Andrea Judge as Chief Executive Officer

Third quarter 2024 earnings released: CA$0.041 loss per share (vs CA$0.10 loss in 3Q 2023)

Little Excitement Around Lifeist Wellness Inc.'s (CVE:LFST) Revenues As Shares Take 33% Pounding

Risks To Shareholder Returns Are Elevated At These Prices For Lifeist Wellness Inc. (CVE:LFST)

Second quarter 2024 earnings released: CA$0.047 loss per share (vs CA$0.097 loss in 2Q 2023)

Lifeist Wellness Inc. announced that it has received CAD 0.45 million in funding

Lifeist Wellness Inc., Annual General Meeting, Aug 16, 2024

Simply Solventless Concentrates Ltd. (TSXV:HASH) (SSC) entered into a share purchase agreement to acquire CannMart Inc. from Lifeist Wellness Inc. (TSXV:LFST) for CAD 2.5 million.

Flora Growth Corp. (NasdaqCM:FLGC) acquired Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV:LFST) for CAD 0.87 million.

Lacklustre Performance Is Driving Lifeist Wellness Inc.'s (CVE:LFST) 50% Price Drop

First quarter 2024 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2023)

Lifeist Wellness Inc. Announces Chief Financial Officer Changes

Full year 2023 earnings released: CA$0.029 loss per share (vs CA$0.045 loss in FY 2022)

Lacklustre Performance Is Driving Lifeist Wellness Inc.'s (CVE:LFST) 50% Price Drop

Lifeist Wellness Inc. Announces Step Down of Meni Morim as CEO

Lacklustre Performance Is Driving Lifeist Wellness Inc.'s (CVE:LFST) 33% Price Drop

Tierra Corp. has entered into a definitive share purchase agreement to acquire CannMart Inc. from Lifeist Wellness Inc. (TSXV:LFST) for CAD 5 million.

Lifeist Wellness Inc., Annual General Meeting, Mar 01, 2024

Lifeist Wellness Inc. (CVE:LFST) Stock Rockets 50% As Investors Are Less Pessimistic Than Expected

Third quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.005 loss in 3Q 2022)

Lifeist Wellness Inc., Annual General Meeting, Dec 29, 2023

Flora Growth Corp. (NasdaqCM : FLGC) entered into a Sale and Purchase Agreement to acquire Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV : LFST) for $1.9 million.

Flora Growth Corp. (NasdaqCM : FLGC) entered into a Sale and Purchase Agreement to acquire Australian Vaporizers Pty Ltd. from Lifeist Wellness Inc. (TSXV : LFST) for $1.9 million.

Lifeist Wellness Inc. Appoints John C. Sinclair to Its Board of Directors

Insufficient new directors

Lifeist Wellness Inc. Announces the Resignation of Barbara Boyd as Director

Second quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.011 loss in 2Q 2022)

New major risk - Market cap size

New major risk - Share price stability

Lifeist Wellness Inc. (TSXV:LFST) agreed to acquire 1000501971 Ontario Inc. from 13735346 Canada and 1000496959 Ontario Ltd for CAD 3.4 million.

Sentiment Still Eluding Lifeist Wellness Inc. (CVE:LFST)

Full year 2022 earnings released: CA$0.045 loss per share (vs CA$0.061 loss in FY 2021)

Lifeist Wellness Inc. announced that it expects to receive CAD 8 million in funding from Alumina Partners (Ontario) Ltd.

Lifeist Wellness Inc. announced that it expects to receive CAD 8 million in funding from Alumina Partners (Ontario) Ltd.

Third quarter 2022 earnings released: CA$0.005 loss per share (vs CA$0.016 loss in 3Q 2021)

Lifeist Wellness Inc., Annual General Meeting, Dec 19, 2022

Second quarter 2022 earnings released: CA$0.011 loss per share (vs CA$0.016 loss in 2Q 2021)

Lifeist Wellness Common Shares to Be Deleted from OTC Equity

Lifeist Wellness Inc. Announces Resignation of Baran Dilaver from Board of Directors

Maropost AB acquired Findify AB from Lifeist Wellness Inc. (TSXV:LFST) for $4.07 million.

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Lifeist Wellness Inc. to Report Q4, 2021 Results on Mar 25, 2022

Independent Director Andrew Wilczynski has left the company

Lifeist Wellness Inc. announced that it has received CAD 0.155 million in funding

Independent Director recently sold CA$52k worth of stock

High number of new and inexperienced directors

Third quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.024 loss in 3Q 2020)

Lifeist Wellness Inc. Provides Earnings Guidance for the Third Quarter of Fiscal Year 2021

Independent Director exercised options to buy CA$62k worth of stock.

Second quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.015 loss in 2Q 2020)

First quarter 2021 earnings released: CA$0.02 loss per share (vs CA$0.023 loss in 1Q 2020)

Namaste Technologies Provides Corporate Update Including Launch of Cannmart.Com in French for Quebec and All Francophones in Canada

Full year 2020 earnings released: CA$0.081 loss per share (vs CA$0.20 loss in FY 2019)

Namaste Technologies Inc. Appoints Slava Klems as Chief Financial Officer

Namaste Technologies Subsidiary CannMart Signs Agreement with HEXO Corp

Namaste Technologies Inc. has completed a Composite Units Offering in the amount of CAD 20.02 million.

Namaste Technologies Inc. to Report Fiscal Year 2020 Results on Mar 30, 2021

If You Had Bought Namaste Technologies' (CVE:N) Shares Three Years Ago You Would Be Down 89%

Namaste Technologies Inc. Announces the Launch of its Consumer-Focused Recreational House Brand "Roilty"

New 90-day low: CA$0.21

Namaste Technologies Inc. (TSXV:N) completed the acquisition of remaining 49% stake in CannMart Inc.

Namaste Technologies Inc. (TSXV:N) entered into a share purchase agreement to acquire remaining 49% stake in CannMart Inc. for CAD 21.5 million.

Price target lowered to CA$0.55

Analysts update estimates

New 90-day low: CA$0.23

Third quarter earnings released

Namaste Technologies Inc. Announces Launch of New Butane Hash Oil Products

Namaste Technologies Announces Trademark Dispute Settlement

Namaste Technologies Inc. Appoints Baker Tilly WM LLP as Auditor

Namaste Technologies Inc Announces Executive Changes

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten